RxDoctor Payments Data

Jamie Gottlieb, MD

Orthopaedic Surgery of the Spine · Irving, TXNPI 1811979842

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (43.7%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Nevro Corp. accounts for 68.8% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2023 at $8,753 and has fallen 92.5% since, to $655 in 2025. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in TX, where the typical reported total is $12,726.

$15,146in general payments, 2019–2025

Across 173 payments — averaging $87.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$10K
  • Abbott$1K
  • MML US, Inc.$1K
  • Amplify Surgical, Inc.$332
  • Seaspine Orthopedics Corporation$301
  • Globus Medical$275
  • plus $1K from 22 others

What the payments were for

  • Consulting fees$4,29028%
  • Speaking & faculty fees$3,12021%
  • Travel & lodging$1,1137%
  • Food & beverage$6,62244%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,146 in reported general payments places this provider in the 50th percentile of 207 orthopaedic surgery of the spine providers in Texas.

See all orthopaedic surgery of the spine providers in Texas →

Medicare billing

Part B allowed, 2024
$60,278
Medicare patients
54
Services billed
308

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin17$1,463
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen73$1,442
Orphenadrine Citrate ErOrphenadrine Citrate13$823
Methocarbamol35$694
Gabapentin38$455
Diclofenac Sodium33$382
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim44$320
Tramadol Hcl22$179
Diazepam13$19

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Irving

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →